Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. cancer characterization
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Books
Downloads

Refine by
Date

  • Older

Cancer Characterization Articles & Analysis

16 news found

CD Genomics Unveils Advanced Whole Genome Sequencing Solutions for Comprehensive Genetic Insights

CD Genomics Unveils Advanced Whole Genome Sequencing Solutions for Comprehensive Genetic Insights

Key advantages of WGS include single base-pair resolution, de novo sequencing and genome-wide mutation characterization, population evolution and phylogenetic studies, and its critical role in disease research, drug discovery, and personalized medicine. ...

ByCD Genomics


CD Genomics Optimized Cancer Hotspot Panel Sequencing Service for Cancer-Related Research

CD Genomics Optimized Cancer Hotspot Panel Sequencing Service for Cancer-Related Research

The company has optimized its Cancer Hotspot Panel Sequencing service to meet the most challenging research process. Cancer is known to cause by the accumulation of harmful genetic mutations within cells. ...

ByCD Genomics


Alfa Chemistry Newly Releases Phospholipids, Modified Lipids, and Functionalized Lipids

Alfa Chemistry Newly Releases Phospholipids, Modified Lipids, and Functionalized Lipids

Cationic lipids are amphiphilic small-molecules serving as versatile tools for delivering DNAs, RNAs, and many other therapeutic molecules and are especially attractive because they can be easily designed, synthesized and characterized. Bioactive lipids are a chemically heterogeneous group of lipids recognized as key mediators of cell growth, adhesion, migration, signaling, and ...

ByAlfa Chemistry


Cleveland Diagnostics Announces Inclusion of IsoPSA in National Comprehensive Cancer Network Guidelines for Prostate Cancer Early Detection

Cleveland Diagnostics Announces Inclusion of IsoPSA in National Comprehensive Cancer Network Guidelines for Prostate Cancer Early Detection

Cleveland Diagnostics, Inc., a clinical-stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers, announced today that its prostate cancer test, IsoPSA, has been added to the National Comprehensive Cancer Network (NCCN) Guidelines for Prostate Cancer Early Detection (version ...

ByCleveland Diagnostics, Inc.


In-depth Mitochondrial Function Testing Services at Creative Biogene

In-depth Mitochondrial Function Testing Services at Creative Biogene

New York, United States—April 21, 2022—Defects in mitochondrial function have long been suspected of contributing to the development of cancer. In this regard, Creative Biogene strives to explore mitochondrial functions that are yet to be discovered as well as the pathogenesis of mitochondria-associated cancers and possible interventions through ...

ByCreative Biogene-Mitochondrial Research


The largest breast AI study to date shows value of Transpara in mammographic screening

The largest breast AI study to date shows value of Transpara in mammographic screening

The Cancer Registry of Norway is one of the oldest and most respected organisations of its kind in the world. ...

ByScreenPoint Medical


OncoDNA provides strategic support in Radiomics` prospective clinical trial SALMON

OncoDNA provides strategic support in Radiomics` prospective clinical trial SALMON

THE TWO BELGIAN COMPANIES WILL WORK TOWARDS A BETTER UNDERSTANDING OF NON-SMALL CELL LUNG CANCER BIOLOGY AND CHARACTERIZATION OF THE TUMORS USING AI TECHNOLOGY Radiomics and OncoDNA are pleased to announce that they have entered into a strategic agreement, combining Radiomics’ next-generation AI-based technology to extract quantitative information embedded ...

ByOncoDNA S.A.


Blue Earth Diagnostics Announces Results of an Analysis of the Impact of Axumin® (Fluciclovine F 18) PET/CT Imaging on Androgen Deprivation Therapy (ADT) Planning in Recurrent Prostate Cancer

Blue Earth Diagnostics Announces Results of an Analysis of the Impact of Axumin® (Fluciclovine F 18) PET/CT Imaging on Androgen Deprivation Therapy (ADT) Planning in Recurrent Prostate Cancer

Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced results of a secondary, post-hoc analysis of data from the prospective LOCATE and FALCON clinical trials that evaluated the impact of Axumin® (fluciclovine F 18) PET/CT imaging on management of patients with recurrent prostate ...

ByBlue Earth Diagnostics


FDA Approves NGS-Based Companion Diagnostic for EGFR Exon20 Insertion Mutant Non-Small Cell Lung Cancer Tumor Tissue

FDA Approves NGS-Based Companion Diagnostic for EGFR Exon20 Insertion Mutant Non-Small Cell Lung Cancer Tumor Tissue

The test is the first and only FDA-approved next-generation sequencing (NGS) CDx on formalin-fixed, paraffin-embedded (FFPE) tissue for determining RYBREVANT eligibility in patients whose disease has progressed on or after platinum-based chemotherapy. Lung cancer is the leading cause of cancer deaths worldwide.1 EGFR mutations are an important therapeutic target ...

ByThermo Fisher Scientific


AptaMatrix, Inc. Receives a NIH Small Business Innovation Research Phase II Award

AptaMatrix, Inc. Receives a NIH Small Business Innovation Research Phase II Award

This assay aims to provide deep analysis of the human plasma proteome for detection and characterization of novel prostate cancer biomarkers. If successful, clinical and research laboratories could use this assay to diagnose cancer and monitor the progress of treatment. If successful, the AP 3 -Assay will be expanded for detection of other ...

ByAptaMatrix, Inc.


NIH Scientists Determine How Environment Contributes to Several Human Diseases

Using a new imaging technique, National Institutes of Health researchers have found that the biological machinery that builds DNA can insert molecules into the DNA strand that are damaged as a result of environmental exposures. These damaged molecules trigger cell death that produces some human diseases, according to the researchers. The work, appearing online Nov. 17 in the journal Nature, ...

ByNational Institute of Environmental Health Sciences (NIEHS)


Agilent Technologies, Cell Line Genetics Collaborate on High-Throughput Cell-Line Characterization Services for Regenerative Medicine, Cancer Researchers

Agilent Technologies, Cell Line Genetics Collaborate on High-Throughput Cell-Line Characterization Services for Regenerative Medicine, Cancer Researchers

(NYSE: A) today announced a collaboration with Cell Line Genetics, Inc., a leading provider of cell-line characterization and quality assurance services. CLG will develop high-throughput, genomic characterization workflows to confirm and monitor the integrity of cell lines for translational and regenerative medicine research. ...

ByAgilent Technologies, Inc.


Agilent Technologies to Collaborate with University of Queensland on Oral Cancer Research

Agilent Technologies to Collaborate with University of Queensland on Oral Cancer Research

Oral cancer is part of a group of cancers commonly referred to as head and neck cancers. ...

ByAgilent Technologies, Inc.


Arsenic turns stem cells cancerous, spurring tumor growth

Researchers at the National Institutes of Health have discovered how exposure to arsenic can turn normal stem cells into cancer stem cells and spur tumor growth. Inorganic arsenic, which affects the drinking water of millions of people worldwide, has been previously shown to be a human carcinogen. A growing body of evidence suggests that cancer is a stem-cell based disease. Normal stem cells are ...

ByNational Institute of Environmental Health Sciences (NIEHS)


EPA releases final health assessment for tetrachloroethylene (perc) / public health protections remain in place

Confirming longstanding scientific understanding and research, the final assessment characterizes perc as a “likely human carcinogen.” The assessment provides estimates for both cancer and non-cancer effects associated with exposure to perc over a lifetime. ...

ByUS EPA - Environmental Protection Agency


NIH-funded researchers discover genetic link to mesothelioma

“The discovery that the BAP1 gene is involved in a new cancer syndrome characterized especially by uveal melanoma and mesothelioma provides yet another example of the critical importance of the detailed genetic analysis of human tumors,” said Donald Blair, Ph.D., NCI. ...

ByNational Institute of Environmental Health Sciences (NIEHS)

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT